info@seagull-health.com
SeagullHealth
语言:
search
new
Usage and dosage of Edaravone injection
501
Article source: Seagull Pharmacy
Jul 23, 2025

Amyotrophic lateral sclerosis (ALS), also known as "Lou Gestational Sickness", is a rare progressive neurodegenerative disease with few treatments. Most patients die within 2 to 5 years after diagnosis. Edaravone is a neuroprotectant that can effectively scavenge free radicals, protecting nerves from oxidative stress and neuronal apoptosis. This article mainly introduces the usage and dosage of Edaravone injection.

Usage and dosage of Edaravone injection

Recommended dose

The recommended dose of Edaravone is 60 mg intravenous infusion, administered within 60 minutes according to the following schedule: the initial treatment cycle is 14 days, daily administration, followed by a 14-day rest period; the subsequent treatment cycle is 14 days, daily administration for 10 days, followed by a 14-day rest period.

How to use Edaravone

Edaravone injection is for intravenous injection only. Do not use if the oxygen indicator has turned blue or purple before opening the package. Once the package is opened, use it within 24 hours. Whenever solution and container permit, injectable drug products should be visually inspected for particulate matter and discoloration prior to administration.

Each 60 mg dose of edaravone injection is given as two consecutive 30 mg IV bags over 60 minutes (infusion rate is approximately 1 mg/minute [3.33 mL/minute]). Stop the infusion immediately at the first observation of any signs or symptoms consistent with an allergic reaction. Other drugs should not be injected into the bag or mixed with edaravone injection.

DOSAGE FORMULATION AND DOSAGE

Edaravone is supplied for intravenous infusion in single-dose polypropylene bags containing 30 mg of edaravone in 100 mL of isotonic sterile aqueous solution. The bags are then repackaged with polyvinyl alcohol (PVA). The outer packaging also contains an oxygen absorber and oxygen indicator to minimize oxidation. Each bag contains the following inactive ingredients: L-cysteine hydrochloride hydrate (10 mg), sodium bisulfite (20 mg). Sodium chloride is added to make it isotonic, and phosphoric acid and sodium hydroxide are added to adjust the pH to 4.

Storage Instructions

Store at 25°C (77°F). Excursions are permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light. Use packaging prior to use to prevent oxygen degradation. Oxygen indicator will turn blue or purple if oxygen exceeds acceptable levels. Once packaging is opened, use within 24 hours.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Can Edaravone be reimbursed by medical insurance?
Edaravone is mainly used in clinical practice to delay amyotrophic lateral sclerosis, also known as ALS. Patients can benefit for up to 1 year. In clinical trials, the ALSFRS-R score of patients in th...
What are the efficacy and effects of edaravone injection?
Edaravone is a brain protective agent (free radical scavenger). It is mainly used to treat acute attacks of cerebral infarction and improve the neurological symptoms, daily living activities and funct...
How should Qalsody be used?
Qalsody is the fourth drug approved by the FDA for the treatment of ALS and the first drug for the treatment of hereditary ALS. How should it be used?How should Qalsody be used?1. Recommended doseThe ...
How effective is Qalsody in treating ALS?
ALS is characterized by progressive muscle weakness, atrophy, muscle twitching, stiffness, and eventually dysphagia and respiratory failure; Qalsody, approved in 2023, is an antisense oligonucleotide ...
Efficacy of edaravone in the treatment of ALS
The main efficacy of edaravone injection is to treat amyotrophic lateral sclerosis (ALS). The following describes the efficacy of edaravone in the treatment of ALS in conjunction with clinical trials....
Indications of Goserelin
Goserelin is a hormone regulator, commonly used to treat hormone-dependent diseases such as breast cancer, prostate cancer, endometriosis, etc. Its therapeutic effect is mainly achieved by inhibi...
Goserelin: Indications Overview
Goserelin is a hormone regulator, commonly used to treat hormone-dependent diseases such as breast cancer, prostate cancer, endometriosis, etc. Its therapeutic effect is mainly achieved by inhibiting ...
Is Goserelin (zoladex) expensive? How much does a box cost?
Goserelin is a synthetic analog of luteinizing hormone-releasing hormone (LHRH), mainly used to treat hormone-sensitive tumors such as prostate cancer and breast cancer. Is Goserelin expensi...
Related Articles
Efficacy of edaravone in the treatment of ALS
The main efficacy of edaravone injection is to treat amyotrophic lateral sclerosis (ALS). The following describes the efficacy of edaravone in the treatment of ALS in conjunction with clinical trials....
Usage and dosage of Edaravone injection
Amyotrophic lateral sclerosis (ALS), also known as "Lou Gestational Sickness", is a rare progressive neurodegenerative disease with few treatments. Most patients die within 2 to 5 years afte...
Can Edaravone be reimbursed by medical insurance?
Edaravone is mainly used in clinical practice to delay amyotrophic lateral sclerosis, also known as ALS. Patients can benefit for up to 1 year. In clinical trials, the ALSFRS-R score of patients in th...
What are the efficacy and effects of edaravone injection?
Edaravone is a brain protective agent (free radical scavenger). It is mainly used to treat acute attacks of cerebral infarction and improve the neurological symptoms, daily living activities and funct...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved